Latanoprost Ophthalmic Solution (VA-27-00006027)
- Client
- Department of Veterans Affairs
- RFP Number
- —
- Posted
- 10/3/2026
- Category
- Software, System and Application
- Budget
- —
- NAICS
- 325412
- Set-aside
- —
- Contact
- Contract Specialist
Description
AI GeneratedThe Department of Veterans Affairs Enterprise Procurement Office needs an uninterrupted supply of Latanoprost Ophthalmic Solution under RFP 36E79727R0039. The selected vendor will supply the drug for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with distribution handled through the VA and DoD Pharmaceutical Prime Vendor Programs. This unrestricted procurement is open to all responsible sources. Offerors must provide a unique National Drug Code (NDC) and exact trade name, place their unique label directly on the product without covering other labels, ensure VA labels securely adhere on top, and follow the American Academy of Ophthalmology's uniform color-coding system for caps and labels. The VA intends to award a single contract with a one-year base period and four pre-priced one-year option periods. RFP 36E79727R0039 will be issued electronically on or about October 21, 2026, on SAM.gov, with a tentative closing date of November 4, 2026. Interested offerors can email questions to James Sullivan.
Official SAM.gov notice
- Solicitation number
- 36E79727R0039
- Agency
- Department of Veterans Affairs
- Buying office
- NAC Pharmaceuticals (36E797)
- Notice type
- Presolicitation
- Responses due
- Oct 16, 2026, 3:30 PM ET
- Posted on SAM.gov
- Oct 2, 2026
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product/service code
- 6505
- Contracting contact
- Contract Specialist, James Sullivan
james.sullivan3@va.gov
708-786-5239
Read the official notice description
PRE-SOLICITATION NOTICE: The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79727R0039 for an unrestricted procurement for Latanoprost Ophthalmic Solution, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. The vendor must follow the American Academy of Ophthalmology s recommended uniform color-coding system for the caps and labels of all topical ocular medications. https://www.aao.org/about/policies/color-codes-topical-ocular-medications Solicitation # 36E79727R0039 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 21, 2026, with a tentative closing date of November 4, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is James Sullivan. Questions can be e-mailed to [email protected]. The estimated annual requirements are as follows:
Source: SAM.gov contract opportunities data (U.S. federal public data).
Incumbent
No incumbent history found for this requirement. The notice does not cite a current contract, and no earlier award from this buying office matches it.
Market context
Awards in the same category (Pharmaceutical Preparation Manufacturing). This is not this requirement's award history.
Recent similar awards: Department of Veterans Affairs, NAICS 325412
| Vendor and award | Value | Ends |
|---|---|---|
| PHARMALOGIC LTD36C24126P0126 · RADIOPHARMACEUTICALS | $135.8K | Dec 31, 2030 |
| CARDINAL HEALTH 414, LLC36C24126P0009 · RADIOPHARMACEUTICALS | $70,000 | Nov 25, 2030 |
| EXELAN PHARMACEUTICALS INC36C24226N0564 · LENALIDOMIDE | $5.3M | May 31, 2029 |
| CARDINAL HEALTH 414, LLC36C26224P0890 · RADIOPHARMACEUTICALS BASE PLUS FOUR OPTION YEARS | $1.4M | Feb 28, 2029 |
| RLS (USA) INC.36C26224P0297 · RADIOPHARMACEUTICALS | $1.1M | Nov 30, 2028 |
Top vendors in this category: Department of Veterans Affairs, NAICS 325412, since Oct 1, 2024
4,098 contract awards in this NAICS over the period.
- 1. MCKESSON CORPORATION$23.5B
- 2. EXELAN PHARMACEUTICALS INC$101.7M
- 3. PROGENICS PHARMACEUTICALS INC$80.5M
- 4. CARDINAL HEALTH 414, LLC$60.3M
- 5. NOVARTIS PHARMACEUTICALS CORPORATION$54.5M
Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.
Verify important details
Document checkConfirm submission instructions and amendments with the issuing agency before responding.
Personalized fit score
Sign up free to see how well this opportunity fits your company — based on your saved profile.
Sign up to see your fit score